- Home
- AMRN vs BRW Comparison
AMRN vs BRW Comparison
Compare AMRN & BRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$13.99
Company Overview
Basic Information| Metric | AMRN | BRW |
|---|---|---|
| Founded | 1989 | N/A |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 273.6M |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | AMRN | BRW |
|---|---|---|
| Price | $13.99 | $6.58 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 82.1K | ★ 291.0K |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $0.35 | $6.38 |
| 52 Week High | $20.90 | $8.49 |
Technical Indicators
Market Signals| Indicator | AMRN | BRW |
|---|---|---|
| Relative Strength Index (RSI) | 41.58 | 43.23 |
| Support Level | $13.65 | N/A |
| Resistance Level | $14.55 | $7.10 |
| Average True Range (ATR) | 0.75 | 0.08 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 21.29 | 58.33 |
Price Performance
Historical Comparison AMRN
BRW
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About BRW Saba Capital Income & Opportunities Fund SBI
Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.